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Abstract
Background: More than half of the patients with type 2 diabetes (T2DM) patients are diagnosed with one or more
comorbid disorders. They can participate in several single-disease oriented disease management programs, which
may lead to fragmented care because these programs are not well prepared for coordinating care between
programs. Comorbid patients are therefore at risk for suboptimal treatment, unsafe care, inefficient use of health
care services and unnecessary costs. Case management is a possible model to counteract fragmented care for
comorbid patients. It includes evidence-based optimal care, but is tailored to the individual patients’ preferences.
The objective of this study is to examine the effectiveness of a case management program, in addition to a
diabetes management program, on the quality of care for comorbid T2DM patients.
Methods/Design: The study is a randomized controlled trial among patients with T2DM and at least one
comorbid chronic disease (N = 230), who already participate in a diabetes management program. Randomization
will take place at the level of the patients in general practices. Trained practice nurses (case managers) will apply a
case management program in addition to the diabetes management program. The case management intervention
is based on the Guided Care model and includes six elements; assessing health care needs, planning care, create
access to other care providers and community resources, monitoring, coordinating care and recording of all
relevant information. Patients in the control group will continue their participation in the diabetes management
program and receive care-as-usual from their general practitioner and other care providers.
Discussion: We expect that the case management program, which includes better structured care based on
scientific evidence and adjusted to the patients’ needs and priorities, will improve the quality of care coordination
from both the patients’ and caregivers’ perspective and will result in less consumption of health care services.
Trial registration: Netherlands Trial Register (NTR): NTR1847
Background
With the ageing of the population and the increase of
prevalence rates of most chronic diseases at older age,
increasingly more patients with a chronic disease also
suffer from other chronic diseases [1]. In the Nether-
lands 25-50% of people with a chronic disease is diag-
nosed with one or more comorbid disorders [2,3]. For
patients with type 2 diabetes (T2DM) this percentage is
even higher, approximately 60% [4].
Comorbid type 2 diabetes (T2DM) patients can partici-
pate in several single-disease oriented disease manage-
ment programs. Disease management programs are
defined as ‘systematic, population-based approaches to
identify persons at risk, intervene with specific programs
of care and measure clinical and other outcomes’.T h e
main goal of disease management programs is to provide
good quality care for a chronic disease and to guarantee
a central role for the patient in managing the disease [5].
However, participating in multiple single-disease
oriented programs in combination with regular primary
care, may lead to fragmented care. In designing these
programs insufficient attention is paid to the possible
comorbid conditions which co-exist with an (index-)
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any medium, provided the original work is properly cited.disease. Comorbid patients are therefore at risk for sub-
optimal treatment, unsafe care, inefficient use of health
care services, unnecessary costs and consequently run
higher risks for adverse events [3,6]. Case management
is a possible model to counteract fragmented care for
comorbid patients. It is an individualized care program
which coordinates all care involved for patients enrolled
in different single-disease management programs, who
have to adhere to various treatment protocols. It draws
on evidence-based optimal care for systematically mana-
ging all existing conditions in a patient, and is tailored
to the individual patients’ preferences [7,8].
There are promising results in a primary care setting
from pilot tests on the effects of case management, in
which an improvement of the quality of chronic care
was observed, especially in the communication, goal set-
ting, decision support, coordination among providers,
and in reducing health care costs [8-12]. Recently, a
study on the effectiveness of case management in the
USA has shown improvement on the self-reported qual-
ity of health care for comorbid elderly [13].
To improve the care for comorbid T2DM patients in
the Netherlands, we used the Guided Care Model (GC)
to design a case management care program customized
to the Dutch primary care setting. In the Netherlands,
every resident is listed in a primary care practice. The
General Practitioner (GP) acts as gatekeeper to second-
ary (specialized) care which is only accessible after refer-
ral. Our aim is to create a comprehensive tool for the
general Practice Nurse (PN), which allows her to man-
age and coordinate the care the comorbid patient needs
and to stimulate involvement of the patient in his care
process. In this study, the PNs will be trained in con-
ducting the case management program and will here-
after be called case manager.
Theoretical framework
GC is developed in the USA and is based on the
Chronic Care Model, a framework to guide quality
improvement and disease management activities in the
care for patients with a chronic disease [10]. GC com-
bines the elements of the Chronic Care Model in prac-
tice and is designed to improve the quality of care and
the quality of life for patients with multiple chronic con-
ditions and complex health care needs [7,10].
GC consists of the following elements: assessing health
care and well-being needs, communicating intervention
possibilities, goal setting and decision support, monitor-
ing and timely evaluation with the patient [10]. These
elements intervene on three levels in the patients’ care
system, on the organizational or practice level (by using
the above mentioned elements), on the level of the care
provider (by using decision support), and on the level of
the patient (by encouraging self management).
Objective
The objective of this study is to establish the additional
value of case management superposed on a diabetes
management program, in terms of perceived quality of
care, quality of care from the perspective of the GP, the
health status of the patient, diabetes control, and health
care utilization in T2DM patients with comorbidity.
Methods/Design
Design of the study
This study is a randomized controlled trial. T2DM
patients with at least one comorbid chronic disease will
be assigned to the control or intervention group. All
patients participate in a diabetes management system
(the Diabetes Care System (DCS), receiving structured
diabetes care. In addition, participants in the interven-
tion group will receive the case management interven-
tion. The duration of the intervention is 12 months.
The Medical Ethics Committee of the VU University
medical centre in Amsterdam approved the study. Parti-
cipants are allowed to enter the study after signed
informed consent. Both the diabetes management pro-
gram (as part of the usual care in the control group)
and the case management intervention will be provided
in the practice in which the patient is listed.
Description of the Diabetes Care System (DCS)
The Diabetes Care System (DCS) is a diabetes man-
agement program, which started in 1996 in the
West-Friesland region of the Netherlands. By incor-
porating the Chronic Care Model, the system aims
at providing comprehensive regional diabetes care,
e d u c a t i n gd i a b e t e sp a t i e n t sa n ds u p p o r t i n gG P si n
treating these patients. By now, nearly 6,500 T2DM
patients are registered at the DCS. All receive an
annual extended diabetes check-up at the specialized
DCS additionally to the diabetes care by their GP
according to the guidelines of the Dutch College of
General Practioners [14]. The basic principles of the
DCS are: the coordination of diabetes care, feedback
to the GP and patient empowerment.
Each patient is invited annually by the DCS for a
physical examination and diagnostic tests such as
blood and urine analysis. In addition, the patient vis-
its a diabetes nurse and a dietician for information
and advice in order to improve the skills and confi-
dence needed for self management. The patients are
invited for follow-up visits when necessary.
The DCS coordinates the diabetes care between pri-
mary and secondary care. Using a centrally orga-
nized database, clinical information of patients is
accessible to involved health care providers. Results
of the annual examination are sent to the patient’s
GP who is responsible for the management of the
patient, delegation of tasks to the PN and the 3-
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from the DCS based on the average results of his
patients compared to all patients participating in the
DCS.
Study population
Practices
Practices delivering diabetes care in cooperation with
the DCS are eligible for participation in this study if
they employ a PN for diabetes care and are willing to
house the case manager.
Patients
Eligible T2DM patients participate in the DCS and are
known with at least one of the following comorbid
conditions: chronic ischemic heart disease [angina pec-
toris, previous myocardial infarction, and heart failure],
stroke, depression, rheumatoid arthritis, osteoarthritis
of hip and/or knee, cancer, chronic obstructive pul-
monary disease. The case manager will identify eligible
patients from the electronic medical record based on
ICPC-codes (International Classification of Primary
Care) representing the included comorbid conditions
(see table 1). Patients are allowed to enter this study
when there is not already a case manager involved,
when they are not suffering from a health problem
which could lead to death within one year, are capable
to give informed consent, to personally fill in question-
naires and have sufficient knowledge of the Dutch
language.
Randomization
Patients will be randomly assigned to the intervention or
control group (see Figure 1). Patients in the control
group will receive care from the DCS, their GP and PN.
Patients in the intervention group will receive the case
management intervention from the case manager in
addition. All eligible patients in the participating prac-
tices will be invited to join the study. Reasons for non
participation will be carefully registered.
Intervention
The case management program is designed to comple-
ment the diabetes management program and therefore
is additional to the care from the DCS. The program
involves six basic elements from the GC model intended
to improve the quality of care for the patient, their
access to care, and their capacity for self care, including
assessing health care needs, planning care, create access
to other care providers and community resources, moni-
toring, coordinating care and recording of all relevant
information [10].
Training
To execute the program properly, the case manager will
be trained in assessing the patients’ health care needs
(step 1) and in creating a care plan based on the assess-
ment (step 2). The case manager will have frequent con-
tacts with the patient, GP and other care providers.
Therefore the case manager will also receive training in
motivational interviewing techniques and communica-
tion strategies, during a 4-day course and two coaching-
on-the-job sessions from a trainer skilled in communica-
tion in health care. MI is a patient-centered counseling
approach and is intended to help the patient make deci-
sions, to facilitate the patient’s participation in care, and
to reconsider the patients’ priorities with the patient.
This method aims at collaboration between the case
manager and the patient, using the patient’si n t r i n s i c
motivation (willingness and motivation for self-care) and
care for their autonomy [17,18]. Furthermore, recogniz-
ing and using different communication strategies in con-
versations will help the case manager in their contacts
with the patient, GP and other care providers. Coach-
ing-on-the-job will be executed by the trainer during
two consults between the case manager and a patient.
The trainer will provide feedback following each consult.
Description of the intervention: the Case Management
Program
The case management program as applied in this
study entails the following steps;
Table 1 International Classification of Primary Care codes of comorbid conditions.
Condition Code
Cancer A79 B72 B73 B74 D74 D75 D76 D77 N74 R84 R85
S77 T71 U75 U76 U77 W72 X75 X76 X77 Y77 Y78
Chronic ischemic heart disease K74 K75 K76
Chronic Obstructive Pulmonary Disease R95
Depression P76
Osteoarthritis of hip and/or knee L89 L90
Rheumatoid arthritis L88
Stroke K90
This table provides an overview of the ICPC-codes corresponding the included comorbid conditions.
ICPC: International Classification of Primary Care
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Before the assessment takes place, the case manager
collects information about the patients’ co-morbid-
ities, treatments and advices, health care utilization
and medication use in the electronic medical
records. The initial assessment takes place with the
patient in a face-to-face intake at the general prac-
tice, by using the Resident Assessment Instrument-
Community Health Assessment (RAI-CHA). The
RAI was originally designed as a minimum data set
to assess the health status of nursing home residents
by identification of problems in 18 areas that may
need specific care planning [19]. The RAI-CHA pro-
vides a comprehensive overview of the patients’
medical, functional, cognitive, affective, psychosocial,
nutritional and environmental status. The identified
problem areas guide the design of an individualized
care plan with the intention to improve or maintain
the functional health status.
Step 2) Start planning care Together with the GP and
the PN responsible for diabetes care, the case manager
creates a provisional care plan. This plan is based on
information from the assessment and currently pro-
v i d e dc a r eb yt h eG Pa n dP N .I nc a s et h ep a t i e n t ’s
health problems results in complex care according to
the GP, a multidisciplinary consultation with all rele-
vant care providers will take place. Regular participants
Figure 1 Design of the study. The figure shows the design of the CasCo-study.
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the DCS (a dietician or diabetes nurse).
Step 3) Discussing the interim care plan with the
patient In a second consultation, the case manager will
discuss the provisional care plan with the patient.
The case manager will give sufficient information as
a result of which the patient will be able to make
decisions related to care or managing the problems
found. Also, the case manager will inform the
patient about community resources relevant to the
patients’ needs. This results in a care plan suitable
to the priorities and needs of the patient and
becomes definite after a final review from the GP,
PN and case manager.
The care plan includes self-management activities
for the patient by setting goals in an action plan (e.g.
regarding nutrition, physical exercise, use of medica-
tion, and self-monitoring) tailored to the patients’
capacities.
Step 4) Communicating the care plan to all involved
care providers The care plan will be communicated to
t h ei n v o l v e dc a r ep r o v i d e r si no r d e rt oc o o r d i n a t e
t h ec a r e .T h ec a s em a n a g e rw i l ln o tt a k eo v e rt h e
care provided by the other care providers, but will
inform them about the patient’s care plan and
explain the case manager’s role.
Step 5) Monthly contact with the patient The case
manager will monitor the patient monthly by tele-
phone to detect and address emerging problems
regarding the implementation of the care plan and
the patients’ health status. If necessary, the case
manager discusses these problems with the GP and
takes appropriate action.
The case manager will review the patient’sa c t i o n
plan and stimulate self-management by coaching the
patient in achieving goals. The case manager will
regularly update the patients’ status and care plan
using the notes from these contacts.
Step 6) Recording During the intervention period, the
case manager will record relevant changes in health
status and all actions undertaken in the patients’
electronic medical record.
Control group
The patients in the control group continue participating
in the DCS. In consequence, the care patients receive in
this group is more extensive than usual care alone. They
receive extended diabetes care from the DCS and usual
care for diabetes (and the comorbid conditions) from
their GP and PN. Care in this group may include the
involvement of a PN, referral to other health care pro-
fessionals, medication reviews, etcetera. These activities
will be monitored and measured as part of our data col-
lection. However, these patients do not participate in
the case management program and therefore will not be
supervised by the case manager.
Measurements
Table 2 provides an overview of all measurements. Data
will be collected using the patients’ electronic medical
record, postal questionnaires, and semi structured
interviews.
To get more insight into the factors favoring and
hampering the implementation of the case management
program, we will perform a feasibility check using semi-
structured in-depth interviews and collect data via
patient questionnaires.
We will interview four groups: 1) all case managers
delivering the intervention, 2) the GPs in the participat-
ing practices, 3) the diabetes nurses of the DCS, as well
as 4) a random stratified selection of 15 patients of the
Table 2 Measurement scheme.
Variable Instrument baseline 3 months 12 months
Primary outcome
a. quality of care perceived by patients CQ-Index GP care
PACIC
X
X
X
X
X
X
Secondary outcomes
b. quality of care perceived by GP Quality Indicators X
c. health status of the patient SF-12 X X X
d. diabetes control Hba1c (%) X X X
e. health care utilization Contacts with care providers X X X
Medication use (RAI-CHA) X X
Feasibility Semi-structured interviews X
This table provides an overview of the time schedule of all measurements and measures.
CQ-Index for GP care: Consumer Quality Index for GP care; GP: General Practitioner; HbA1c: glycated haemoglobin level; PACIC: Patient Assessment of Chronic
Illness Care; RAI-CHA: Resident Assessment Instrument - Community Health Assessment; SF-12: Short-Form 12.
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questionnaire having been exposed well and poorly to
the case management program). The interviews will be
recorded using a voice recorder.
Outcome assessment
Primary and secondary outcome measurements are
assessed at baseline, at 3 and 12 months. Interim ana-
lyses will be carried out three months after the baseline
measurement. This analysis will be purely descriptive
concerning changes in the quality of the received care
according to the patient as a result of participation in
the case management program.
Primary outcome measures
The quality of care as perceived by the patient, will be
measured with the experience part of the multidimen-
sional questionnaire Consumer Quality Index for GP
care (CQ-Index)[20]. The CQ-Index is a standardized
systematic way of measuring, analyzing and reporting
clients’ experiences in care. The ‘tailored care’ subscale
includes 4 items, to be scored on a 4-point scale and
has been shown to be reliable (Crohnbach’sa l p h a=
0.84)[21].
Additionally we will use the Patient Assessment of
Chronic Illness Care questionnaire (PACIC), a 20-item
questionnaire which measures patient-reported quality
of chronic illness care. It can be used to determine
whether the received care is patient-centered, proactive,
planned and includes collaborative goal setting; pro-
blem-solving and follow-up support [22].
Secondary outcomes measures
The quality of care perceived by the GP will be mea-
sured using a validated set of basic quality indicators
[23,24]. Quality Indicators define the degree to which
the provided care is in accordance with the evidence-
based guidelines. They are usually calculated as percen-
tages based on patient data registered in the electronic
medical record and from completed questionnaires.
Additionally, the Primary Care Assessment Tool provi-
der survey (PCAT) will be used in a semi-structured
interview to measure the quality of care from the per-
spective of the GP as well. The PCAT provides informa-
tion on structure and process elements of primary care.
This also includes information on patient-, provider-,
and facility-related perspectives on the experiences of
care received and care provided [25].
The health status of the patient will be assessed by the
Short Form 12 (SF-12). This is a multi-purpose generic
health status questionnaire, including 12 items scoring
on a physical and a mental health scale.
Diabetes control will be measured by means of the
glycated haemoglobin level (HbA1c). The HbA1c indi-
cates the glucose control over the past 2-3 months and
will be measured at baseline and after 12 months.
Health care utilization will be measured by the num-
ber of visits patients make to different health care pro-
fessionals and changes in the medication lists. This
information will be collected through a patient question-
n a i r ew h i c hw a sp r e v i o u s l yu s e di nt h es e c o n dD u t c h
National Survey of General Practice [26], adapted from
the Health Questionnaire of Statistics Netherlands [27].
The questions include involvement of all relevant health
care provided. Changes in the medication lists will be
measured by comparing the patients’ medication lists at
the beginning and end of the intervention period.
Sample size
The required sample size for this study is calculated on
the basis of the main outcome measure, the ‘tailored
care’ subscale of the CQ-Index. Previous research
showed mean baseline scores of 3.1 (SD 1.0) on a 5-
point scale [20]. We expect a mean improvement of 0.4
in the intervention group and 0.1 in the control group
(mean difference in improvement 0.3). Assuming a
pooled SD of change of 0.75 (SMD = 0.40), we would
need complete data for 98 patients in each group; given
80% power and a significance level of 5%. We will
recruit 2 × 115 patients allowing a drop-out rate of 15%
during follow-up.
Analyses
The effectiveness of case management will be estab-
lished in multivariate multilevel analyses, according to
the intention-to-treat principle. When possible, specific
attention will be paid to identify subgroups of patients
characterized by their profile of comorbidity in which
the intervention is more effective than in other sub-
groups. The data might allow calculating an individual
case management exposure level score, in the interven-
tion group as well as in the control group. This will
enable analyses of the outcome measures according to
the per-protocol principle. Differences between patients
exposed to the case management program and patients
in the control condition on patient’s health care utility
and patient’s health status will be tested using a chi-
square test and student t-test, respectively. Potential
confounding is checked, including the effect of different
case managers and the number of patients per case
manager.
Discussion
I nt h i sp a p e rw ed e s c r i b et h ed e s i g no far a n d o m i z e d
controlled trial of a case management program led by a
trained PN, the case manager, for comorbid T2DM
patients. The project will represent a first step in the
evidence about the effectiveness of a primary care based
case management program by studying the effectiveness
in the Dutch primary care setting of a program which
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superposing this case management program on a dia-
betes management program, we will also be able to
identify its additional value compared to a single disease
oriented management program.
We expect that better structured care based on scien-
t i f i ce v i d e n c ea n da d j u s t e dt ot h ep a t i e n t s ’ needs and
priorities can improve the quality of care coordination
from both the patients’ and caregivers’ perspective and
can result in less consumption of health care services.
Patients with more than one chronic condition might
need support to coordinate their care arrangements.
This is reflected by the choice for quality of care as per-
ceived by the patient as the main outcome measure.
When case management superposed on diabetes man-
agement is more effective than diabetes management
alone, many patients will benefit from a better organized
care, better health outcomes, and more efficient use of
health care services. From a societal perspective, effec-
tive case management will lead to more efficient health
care utilization, and consequently lower costs.
The major strength of this study is the close fit to the
normal procedure in primary care practice and the not
invasive character of the case management program.
Experiments with case management as proposed in this
study are a logical next step in pursuing optimal care
for diabetics with comorbidity, with the knowledge that
more than 60% of the diabetics have one or more
comorbid disorders. Also, when people get older, the
prevalence of chronic illnesses increases. Taking this
into account, care for comorbid diabetics can become
very complex to manage. The model of case manage-
ment superposed on disease management for diabetics
can be seen as exemplary and it will be worthwhile to
apply the results - if positive - to other single-disease
management programs for other chronic diseases.
The designed program is based on the Guided Care
Model which is under study in the USA. There are
three major differences between the implementation of
the case management program in the USA and the cus-
tomized version in our study.
At first, we do not screen for eligible patients based
on their health care consumption (or costs) or based on
frailty measures. We have chosen to include a group of
patients already enrolled in a diabetes management pro-
gram, who are diagnosed with multiple chronic condi-
tions. Because they have multiple chronic conditions,
they could participate in several disease management
programs. These programs aim at structuring and
managing all care necessary according to the evidence-
based guidelines for the specific chronic disease. How-
ever, these programs are not designed to complement
each other and could increase burden and costs for the
patients, especially when there are multiple
comorbidities present. For that reason the question
whether case management has any additional value over
the structured diabetes management and if so, for which
patients with comorbidity, is very important. This is also
a core subject of the ZonMw research program on dis-
ease management, who provide funding for this study.
Secondly, the case manager in our study is less exten-
sively involved in coordinating the patients’ care than in
the USA and for example does not coordinate transi-
tions between sites (from hospital back to home or vice
versa). When a patient is in hospital, the case manager
will be informed by the patient, family or hospital. The
case manager will contact the patient when he or she is
still in hospital or after discharge to discuss and, if
necessary, adjust the care plan. Participants in this study
are not institutionalized. They are motivated and
empowered during this intervention to contact the case
manager if problems or changes in health status occur.
Important is the emphasis on patient priorities and
patient self management, monitored by monthly tele-
phone contacts, which also implies that patients are
responsible for keeping the case manager up-to-date.
Thirdly, we do not include training for the patient’s
informal caregivers, because the participants in this
study are expected not to be severely frail. We are
aware of the burden informal caregivers often face and
therefore they are welcome to accompany their spouses
during their participation in the case management
program.
This study had some limitations in the design that
might influence the reliability and validity of this study,
which we have to address.
Our study population is a standardized group of
T2DM patients already receiving structured diabetes
care in a diabetes management program.
This could influence the external validity of the study.
However at this moment the majority of the T2DM
patients in the Netherlands are included in a disease
management program, which means that structured dia-
betes management is more or less ‘usual care’ in pri-
mary care. Therefore we expect our study results to be
generalizable, meaning it can be translated to a larger
group of comorbid diabetics in the Netherlands.
We look at the additional value of the case manage-
ment program next to an existing disease management
program. This means that using a selected standardized
population has its benefits. The patient’s health is moni-
t o r e de v e r y3m o n t h sa tt h eG Pa n dt h ei n f o r m a t i o ni n
the medical records should be up-to-date.
We identify possible participants by reviewing the
electronic medical record at the general practice, using
disease specific (ICPC) codes. Mental illnesses such as
depression are often not well recognized or diagnosed in
primary care. We might miss out on patients with this
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study will receive the case management program tai-
lored to somatic disorders.
I nt h i ss t u d yw et r a i n e dt w oP r a c t i c eN u r s e st oc o n -
duct the program. They will include 230 participants in
this study, which means a caseload of 115 participants
per person - half enrolled in the intervention group and
half receive usual care. These participants are divided
over multiple primary care practices. Differences in
results between participants managed by the case man-
agers can occur. To avoid bias due to the number of
case managers we will check the data for cluster-effect
by case manager.
The case managers work together with the PN and
GP to discuss the results from the initial assessment
a n dd u r i n gt h ed e s i g no ft h ec a r ep l a nb e f o r ei ti sp r e -
sented to the patient. During this contact the GP and
PN might get motivated to use specific elements in the
usual care group, who do not receive the intervention.
This could lead to contamination. However, the GP
a n dP Na r en o ti n v o l v e di nt h ep r o g r a m( t h ea c t u a l
problem assessment with the patients, the monthly
monitoring, the contacts between the case manager
and participant) and therefore we expect this form of
contamination, if it occurs, will be washed out in a
short period and will not influence the intervention
effect after 12 months.
This study started in October 2009 by designing the
program and making all practical arrangements for the
start and implementation of the intervention. In Febru-
ary 2011 the first patients were included in the study.
Follow-up of patients will continue until July 2012.
The results of this study will become available at the
beginning of 2013.
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